OTCMKTS:ENZN
Enzon Pharmaceuticals Stock Company Profile
$0.0780
+0 (+0%)
At Close: Apr 24, 2024
Information
20 Commerce Drive, Suite 135
Cranford NJ 07016
732 980 4500
www.enzon.com
Industry: Biotechnology
Sector: Healthcare
Description
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
